Research Grade Reta
Research Grade Reta
Couldn't load pickup availability
Payment options
Place your order securely through our website and complete payment via PayID.
- PayID
- Ships the same business day when ordered before 1pm AEST, tracked with Australia Post
- Free shipping within Australia on orders over $250Free shipping on every order this week
- Cold-chain packed, with free bacteriostatic water on every order this week
Lab report
The independent lab report for the current batch is being uploaded. Ask us for a copy in the meantime.
The most potent metabolic research peptide available.
LY3437943 is a first-in-class triple-receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. Phase 3 TRIUMPH clinical data demonstrated 28.7% average body weight reduction ā the highest efficacy ever recorded for a metabolic compound in clinical trials.
Triple Receptor Mechanism
Simultaneously targets GIP, GLP-1, and glucagon receptors. The glucagon pathway increases energy expenditure and fat oxidation ā a mechanism no single or dual agonist achieves.
99%+ Purity ā Third-Party Verified
Every batch independently tested via HPLC and mass spectrometry. Certificate of Analysis available for download. Molecular weight confirmed at ~4,472 Da.
Phase 3 Clinical Data
TRIUMPH-4: 28.7% weight loss at 68 weeks. TRANSCEND-T2D-1: 2% A1C reduction + 16.8% weight loss at 40 weeks. No plateau observed ā participants still losing weight at trial end.
Reconstitution Ready
Recommended: 2ml BAC water ā 10mg/ml concentration. 1mg = 20 units on a U-100 syringe. Full reconstitution table available in our guide.
Storage: Lyophilised: -20Ā°C (long-term) or 2ā8Ā°C (short-term). Reconstituted: 2ā8Ā°C, use within 28 days. Never freeze after reconstitution. Avoid repeated freeze-thaw cycles.
All products sold by Tidal Peptides are intended strictly for laboratory and research use only. Not for human consumption. By purchasing, you agree to our Terms of Service.
